Please assess the completion status of the following clinical trial:

Trial Title: Local Anesthetic Treatment of Oral Pain in Patients With Mucositis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosed with head/neck cancer and starting radio therapy treatment~* age between 18 and 80 years (both included)~* able to talk, read and understand Danish~* ability to give informed consent~Exclusion Criteria:~* known hypersensitivity towards bupivacaine or other local anesthetics of the amide type~* pregnancy~* women breastfeeding a child

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Bupivacaine lozenge (Type: ACTIVE_COMPARATOR): The patients can take up to eight 25 mg bupivacaine lozenges (max. every second hour in the awake hours) a day for seven days. The patients can use concomitant systemic pain treatment (e.g. morphine).
- Standard treatment (Type: OTHER): The patients will be treated with the currently used standard pain treatment (lidocaine viscous solution, morphine, paracetamol, NSAID, gabapentin). The anesthetics are being administered at the physician's discretion.

Based on this trial design, predict the completion outcome and termination type (if applicable).